Corneal dystrophies (CDs) are a group of hereditary disorders that generally become apparent in the first or second decades and are characterized by progressive accumulation of deposits in the cornea layers resulting in low corneal transparency \[[@ref1]\].

Granular corneal dystrophy (GCD) has an autosomal dominant inheritance and causes focal white, snowflake-like opacities in the corneal stroma \[[@ref2]\]. Type 1 is the most common type of granular dystrophy as characterized by multiple discrete crumb-like corneal opacities \[[@ref1]--[@ref3]\]. It usually begins in the first decade of life or in puberty with grayish-white opacities involving the superficial corneal stroma \[[@ref4], [@ref5]\]. The opacities increase in number, expand, spread peripherally, and become deeper due to accumulation. However, a clear zone remains in the peripheral cornea. Finally, disk-shaped opacities are formed in the central cornea in the third or fourth decades \[[@ref5]\].

Keratoconus is a disorder of corneal ectasia with nearly equal incidence in male and female populations and often occurs in the second decade of life. The diagnosis might be missed unless corneal topography is performed especially in early or mild cases \[[@ref6]\]. The etiology and pathogenesis of keratoconus are not fully understood. Some genetic, environmental, biomechanical, and biochemical mechanisms have been proposed with various hypotheses \[[@ref6]\]. There are many reports on keratoconus and coexisting ocular conditions, such as CDs, retinitis pigmentosa, and Leber's congenital amaurosis, but few reports discuss the association of keratoconus with GCD \[[@ref7]--[@ref13]\].

The association of keratoconus and GCD has been reported as case reports in the literature, but this association was noticed in four generations of a family in the present study. The study conducted by Mitsui et al. \[[@ref14]\] is the first familial case series with respect to the association of keratoconus and GCD. To the best of our knowledge, this is the second familial case series in the literature.

MATERIALS AND METHODS {#sec1-2}
=====================

Clinical Examination {#sec2-1}
--------------------

Best-corrected visual acuity (BCVA) test, biomicroscopic examination, and fundus examination were performed on 22 patients for family screening.

Corneal topography was performed on both eyes of adult patients with a diagnosis of granular dystrophy and all cases aged \>5 years with normal ocular examination (except two non-compliant children aged 5 and 6 years). In addition, GCD cases were photographed in both eyes (except one case who did not want his photograph taken).

The Pentacam Scheimpflug system (Oculus, Wetzlar, Germany) was used for corneal topography. Topographic evaluation was evaluated based on the study by Ucakhan et al. \[[@ref15]\] who used seven topographical evaluation models to determine keratoconus. Our study was based on Model 6 that contains the measurements of classic keratoconus changes in the cornea and parameters obtained from the posterior map of the cornea. These parameters are as follows: flat keratometry, steep keratometry, mean keratometry, central corneal thickness, minimum corneal thickness, MaxP4A\*, MaxP4P\* obtained with the posterior corneal map, MaxPE5\*, MaxPD5\*, PEDD\*, PEDD/BFS\*, and PER\* (\*the abbreviations for these indices are explained in Appendix A).

All patients diagnosed with GCD with keratoconus and/or subclinical keratoconus were referred to the internal medicine, cardiology, and rheumatology departments regarding systemic diseases.

The study was approved by the local ethics committee of Inonu University. Consent forms were obtained from all patients who were enrolled in the study.

Cases {#sec2-2}
-----

The cases were listed by their location in the pedigree ([Fig. 1](#F1){ref-type="fig"}). This ranking was created by using the generation and sequence in the generation. There was no positive family story for patients with keratoconus and granular dystrophy. In addition, atopic signs, connective tissue diseases, or systemic diseases, such as diabetes, were not observed, and no patient had a history of refractive or non-refractive ocular surgery.

![Demonstrating the four generations of affected members of the family pedigree (y: Years).](NCI-6-176-g001){#F1}

**Case 1 (pedigree no. II-1):** A 60-year-old mother of our proband case. She had no ocular complaint. Her BCVA was 20/20 unaided bilaterally. Bilateral slit lamp biomicroscopy revealed symmetrical, sharply demarcated, non-coalescent, grayish-white opacities only in the stroma layer ([Fig. 2](#F2){ref-type="fig"}). The stroma between the opacities was transparent, and no epithelial defects or stromal haze was noted. Anterior segment and fundus examination results were within the normal limits in both eyes. She was diagnosed with bilateral subclinical keratoconus by topographic examination according to Ucakhan et al. \[[@ref15]\] ([Fig. 3A](#F3){ref-type="fig"}, [Fig. 3B](#F3){ref-type="fig"}).

![Left eye corneal photograph of Case 1. Opacities of granular corneal dystrophy were seen in the corneal stroma.](NCI-6-176-g002){#F2}

![**(A)** Subclinical keratoconus findings in the right eye topograph of Case 1 (mother of the proband). **(B)** Subclinical keratoconus findings in the left eye topograph of Case 1 (mother of the proband).](NCI-6-176-g003){#F3}

**Case 2 (pedigree no. II-2):** A 55-year-old aunt of our proband case. She had no ocular complaint. Her BCVA was 20/20 unaided bilaterally. On biomicroscopic inspection of the cornea, symmetrical, sharply demarcated, grayish-white, non-coalescent, star-shaped specular mild opacities were found only in the stroma layer. The stroma between the opacities was transparent, and no epithelial defects or stromal haze was noted. Anterior segment and fundus examination results were within the normal limits in both eyes. She was diagnosed with bilateral subclinical keratoconus by topographic examination.

**Case 3 (pedigree no. II-4):** A 41-year-old other aunt of our proband case. She complained of blurred vision in both eyes. BCVA was 20/20 (−1.5−2.25×25) in the right and 20/20 (−1.00−1.5×165) in the left eye. A Fleischer's ring was seen in both eyes without any anterior or posterior segment pathology on biomicroscopic examination. She was diagnosed with bilateral clinical keratoconus by topographic examination.

**Case 4 (pedigree no. III-2):** This was the first diagnosed case, a 35-year-old female. She presented at our outpatient clinic with complaints of bilateral blurred vision. BCVA with contact lenses was 20/30 in the right eye (spherical value of contact lens: s−9.0) and 20/30 in the left eye (spherical value of contact lens: −9.5). Corneal ectasia with the presence of Vogt's striae and a Fleischer's ring and sharply demarcated, grayish-white, non-coalescent, star-shaped opacities localized only to the stroma were found bilaterally on biomicroscopic examination ([Fig. 4](#F4){ref-type="fig"}). Anterior segment and fundus examination results were within the normal limits in both eyes. She was diagnosed with bilateral clinical keratoconus by topographic examination ([Fig. 5A](#F5){ref-type="fig"}, [Fig. 5B](#F5){ref-type="fig"}).

![Right eye photograph of the proband (Case 4). Sharply demarcated, grayish-white, non-coalescent, star-shaped opacities localized only to the stroma.](NCI-6-176-g004){#F4}

![**(A)** Keratoconus findings in the right eye topograph of the proband (Case 4). **(B)** Keratoconus findings in the left eye topograph of the proband (Case 4).](NCI-6-176-g005){#F5}

**Case 5 (pedigree no. III-3):** A 34-year-old sister of our proband case. She had no ocular complaint. Her BCVA was 20/20 unaided bilaterally. Biomicroscopic inspection revealed bilateral and symmetrical, sharply demarcated, grayish-white, non-coalescent, star-shaped specular mild corneal opacities only in the stroma layer. The stroma between the opacities was transparent, and no epithelial defects or stromal haze was noted. The anterior segment and fundus examination results were within the normal limits in both eyes. She was diagnosed with bilateral subclinical keratoconus by topographic examination.

**Case 6 (pedigree no. III-5):** A 22-year-old other sister of our proband case. She had no ocular complaint. Her BCVA was 20/20 unaided bilaterally. Similar to other cases, bilateral and symmetrical, sharply demarcated, grayish-white, non-coalescent, star-shaped specular mild opacities were seen only in the stroma layer on biomicroscopic examination. The stroma between the opacities was transparent, and no epithelial defects or stromal haze was noted. Anterior segment and fundus examination results were within the normal limits in both eyes. She was diagnosed with bilateral subclinical keratoconus by topographic examination.

**Case 7 (pedigree no. IV-4):** A 10-year-old daughter of our proband case. She had no ocular complaint. Her BCVA was 20/20 unaided bilaterally. Similar to other cases, bilateral and symmetrical, sharply demarcated, grayish-white, non-coalescent, star-shaped specular mild opacities were seen only in the stroma layer on biomicroscopic examination ([Fig. 6](#F6){ref-type="fig"}). The stroma between the opacities was transparent, and no epithelial defects or stromal haze was noted. Anterior segment and fundus examination results were within the normal limits in both eyes. She was diagnosed with bilateral subclinical keratoconus by topographic examination ([Fig. 7A](#F7){ref-type="fig"}, [Fig. 7B](#F7){ref-type="fig"}).

![Left eye corneal photograph of Case 7. Opacities of granular corneal dystrophy were seen in the corneal stroma.](NCI-6-176-g006){#F6}

![**(A)** Subclinical keratoconus findings in the right eye topograph of Case 7 (daughter of the proband). **(B)** Subclinical keratoconus findings in the left eye of Case 7 (daughter of the proband).](NCI-6-176-g007){#F7}

RESULTS {#sec1-3}
=======

A total of 22 cases were examined in this family screening study, and clinical and/or subclinical keratoconus was identified in seven cases ([Table 1](#T1){ref-type="table"}). Of the seven cases, six were diagnosed with GCD type 1. All cases diagnosed with keratoconus or GCD were females, and the males were healthy. Judging by the pedigree view ([Figure 1](#F1){ref-type="fig"}), the disease appears to have an autosomal dominant transition. However, the onset of disease only in women suggests that there might be a variant expression.

###### 

Corneal topographic data of the seven patients with keratoconus and/or subclinical keratoconus

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  The data of topography   Cutoff value for keratoconus^[†](#t1f1){ref-type="table-fn"}^   Cutoff value for Subclinical keratoconus^[‡](#t1f2){ref-type="table-fn"}^   Case-1\      Case-2\      Case-3\      Case-4\                                        Case-5\       Case-6\       Case-7\                                                
                                                                                                                                                                       (no: II-1)   (no: II-2)   (no: II-4)   (no: III-2)^[¥](#t1f3){ref-type="table-fn"}^   (no: III-3)   (no: III-5)   (no: IV-1)                                             
  ------------------------ --------------------------------------------------------------- --------------------------------------------------------------------------- ------------ ------------ ------------ ---------------------------------------------- ------------- ------------- ------------ ------ ------ ------ ------ ------ ------ ------
  Kf (D)                   42.95                                                           NA                                                                          44.1         44.2         42.6         43.1                                           44.4          45.5          48.2         46.7   44.4   44.4   44.2   45.3   43.2   44.0

  Ks (D)                   44.8                                                            44.45                                                                       44.2         42.9         43.5         43.6                                           46.7          43.9          51.6         49.4   46.6   46.2   45.5   46.0   43.5   42.1

  Km (D)                   43.97                                                           NA                                                                          44.1         43.7         43.0         43.3                                           45.5          44.7          49.8         48.0   45.5   45.3   44.9   45.7   43.4   43

  CCT (μm)                 502.5                                                           511.5                                                                       504          500          505          491                                            505           497           451          450    489    479    491    473    561    551

  CTmin (μm)               493.5                                                           497.5                                                                       501          497          503          488                                            493           481           400          418    488    475    487    468    561    544

  MaxP4A (D)               47.30                                                           45.85                                                                       45.6         45.7         44.4         43.7                                           50.2          50.7          61.4         58.6   46.8   46.8   46.4   46.1   45.9   44.8

  MaxP4P (D)               -8.3                                                            -7.15                                                                       -6,7         -6.6         -6,4         -6.1                                           -8.1          -8.0          -9.9         -9.4   -7     -6.9   -6.8   -6.8   -6.6   -6.7

  MaxPE5 (μm)              26.5                                                            20.5                                                                        40           55           52           42                                             57            82            127          112    47     49     66     29     35     36

  PER                      4.96                                                            2.89                                                                        6.22         8.55         7.79         6.26                                           9.12          13.1          22.0         19.0   7.85   8.19   10.8   4.71   5.51   5.66

  MaxPD5 (μm)              -57.5                                                           -33.5                                                                       -23          -28          -19          -20                                            -111          -104          -153         -115   -26    -32    -33    -21    -42    -35

  PEDD (μm)                60.0                                                            46.5                                                                        63           93           71           62                                             168           186           290          227    73     81     99     50     77     71

  PEDD/BFS                 7.96                                                            6.70                                                                        9.79         14.4         10.6         9.25                                           26.8          29.7          50.4         38.6   12.2   13.5   16.2   8.13   12.1   11.1
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Cut-off value for keratoconus according to Ucakhan et al.;

Cut-off value for subclinical keratoconus according to Ucakhan et al.;

Proband, the first diagnosed case; R: Right eye; L: Left eye;

Keratoconus;

Subclinical keratoconus; Kf: Flat keratometry; Ks: Steep keratometry; Km: Mean keratometry; CTmin Z: Minimum corneal thickness; MaxP4A: Maximum anterior corneal power at central 4.0 mm; MaxP4P: Maximum posterior corneal power at central 4.0 mm; MaxPE5: Maximum posterior corneal elevation above the BFS; MaxPE5: Maximum posterior corneal elevation above the BFS; PER: posterior elevation ratio (=MaxPE5/BFS); PEDD: Posterior elevation depression difference (=MaxPE5 -MaxPD5); NA: Not analyzed because no significant differences were obtained.

Internal medicine, cardiology, and rheumatologic examination results were all reported as normal.

Genetic Research Result {#sec2-3}
-----------------------

Corneal examination revealed keratoconus in seven out of 15 cases. All of the affected cases were females. In six out of these seven cases, keratoconus and GCD association was detected. In seven cases diagnosed with keratoconus, the previously defined G160D mutation was detected.

DISCUSSION {#sec1-4}
==========

The possible causes and mechanisms of keratoconus are poorly understood despite studies to elucidate the etiology and pathogenesis of the disorder in recent years. Associations with some genetic--biochemical findings and some disorders, such as ocular or systemic, have been demonstrated. There are few reported sporadic cases on keratoconus associated with granular dystrophy. In the present study, familial GCD cases associated with keratoconus were reported. To our knowledge, this is the first study on familial GCD cases associated with keratoconus shown in the literature.

Keratoconus is generally known as an isolated condition, but has also been described in association with many syndromes or disorders \[[@ref8], [@ref16]\], such as Down's syndrome \[[@ref17], [@ref18]\], Leber's congenital amaurosis \[[@ref19]\], Ehler-Danlos syndrome \[[@ref20]\], osteogenesis imperfecta \[[@ref21]\], mitral valve prolapse \[[@ref22]\], atopy \[[@ref23], [@ref24]\], and vernal keratoconjunctivitis \[[@ref25]\]. Therefore, systemic evaluations were performed for all patients in our familial screening study, and none of the individuals was found to have a disorder that could be associated with keratoconus.

We believe that the incidence of keratoconus and granular dystrophy association may be higher than mentioned in past reports of the literature as the early stages of keratoconus may not be detected on routine eye examination. In addition, the keratoconus incidence has changed significantly after the introduction of corneal topography. The rate of keratoconus in close relatives of patients with keratoconus was reported to be 6%--8% before topographic cornea examination was available and increased to 50% in recent studies \[[@ref26]--[@ref28]\].

The GCD and keratoconus association (clinical and subclinical keratoconus) was demonstrated in each female case in the present study. Our topography device and the keratoconus diagnosis model \[[@ref15]\] that was developed for this device to demonstrate early keratoconus may have influenced this presentation as there was no keratoconus diagnosis model in previous studies.

Keratoconus has been suggested to have autosomal dominant inheritance with variable expression, and GCD has autosomal dominant inheritance \[[@ref27]--[@ref30]\]. The association of GCD and keratoconus had an autosomal dominant inheritance, but it is interesting that all affected individuals were females in our study, and this has not been previously reported in the literature. We believe that this might be a variant expression of autosomal dominant inheritance and have now consulted the Genetics Department for genetic research.

Many theories propose that the development of keratoconus is a result of the structural component loss of the cornea. Factors involved in the development of keratoconus have been identified as increased corneal proteolytic enzyme and interleukin-1 receptor levels, decreased proteinase inhibitor levels, and collagen type XIII, XV, and XVII changes \[[@ref30]--[@ref35]\]. Anterior stromal keratocyte loss, increase of interleukin-1 and interleukin-6, and decrease of interleukin-10 have been identified, and thinning of the corneal stromal lamellar structure and oxidative damage are found to be effective in the formation of keratoconus in other studies \[[@ref36]--[@ref46]\].

Various cells, collagen types, enzymes, and other mediators have shown to be influential in the development of keratoconus. However, more detailed investigation of these cells and mediators is needed to reveal the etiology of GCD and understand why keratoconus develops in patients with GCD. We could not perform such a study for ethical reasons as the patients had a good level of vision. Histopathological examination will be possible in the future if the patients require keratoplasty. Therefore, useful information for understanding the association of these two clinical entities could be obtained.

The coexistence of keratoconus and GCD was described for the first time by Mitsui \[[@ref14]\] who reported the association of keratoconus and corneal granular dystrophy in a mother and her two sons. However, one of the sons had only keratoconus. We observed the association of keratoconus and corneal granular dystrophy only in the females of the four generations.

We believe that this association has an autosomal dominant inheritance with a different expression. Further studies are needed to clarify the etiology of this association.

Our study has limitations. One important limitation of the study is the number of subjects. We believe that more valuable results could be obtained if all of the family members could be included in the study. Another important limitation of our study is inadequate genetic analyses. Although we have found an association between corneal granular dystrophy and keratoconus disease, and we think that this association is caused by a variant expression, the clear localization and definition of this variant gene could not be identified.

In conclusion, the present study showed a familial association of GCD and keratoconus in four generations. The present study also showed autosomal dominant inheritance with a variant expression.

Appendix {#sec2-4}
--------

BFS=best-fit sphere

MaxP4A=maximum power measurement at the central 4.0 mm of the anterior corneal surface. Obtained by moving the cursor to the steepest point on the anterior sagittal curvature map.

MaxP4P=maximum power measurement at the central 4.0 mm of the posterior corneal surface. Obtained by moving the cursor to the steepest point on the posterior sagittal curvature map.

MaxPD5=maximum depression value below the BFS at the central 5.0 mm of the posterior elevation map. Obtained by moving the cursor to the lowest point on the posterior elevation map.

MaxPE5=maximum elevation value above the BFS at the central 5.0 mm of the posterior elevation map. Obtained by moving the cursor to the highest point on the posterior elevation map.

PEDD=posterior elevation depression difference. Obtained from the posterior elevation data. The highest minus the lowest value above and below the BFS (PEDD=MaxPE5−MaxPD5).

PEDD/BFS=obtained from the posterior elevation data. The posterior elevation depression difference divided by the BFS.

PER=posterior elevation ratio. Obtained from the posterior elevation data. The maximum elevation value above the BFS at the central 5.0 mm of the posterior elevation map divided by the BFS (PER=MaxPE5/BFS).
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